I agree with you ref Covid testing for now but HIV is their flagship product and it was even before listing. with their recently announced agreements on HIV, I doubt they will not be able to become an important player in the HIV testing market. imo we have HIV and Lumos for now ...but I expect other applications in the long term.
AT1 FY21 - General Discussion + FA, page-1440
-
- There are more pages in this discussion • 994 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AT1 (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $14.06M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 664492 | 2.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.2¢ | 7674 | 2 |
View Market Depth
| Last trade - 16.12pm 16/10/2024 (20 minute delay) ? |
| AT1 (ASX) Chart |
Day chart unavailable